Search Publications

Publications

Pubmed ID Author Year Title

8287579

Conway GS

1993

Clinical implications of hyperinsulinaemia in women.

8288049

Moller DE

1994

Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance.

8289851

Rodin A

1994

Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase.

8290301

Elkind-Hirsch KE

1994

Sex hormones regulate ABR latency.

8291452

Szil?gyi A

1993

Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease.

8291453

Mallya S

1993

Measurement of serum levels of exogenously administered FSH and LH during ovulation induction therapy.

8291455

Prelevi? GM

1993

24-hour serum cortisol profiles in women with polycystic ovary syndrome.

8293841

Lemay A

1994

Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents.

8297840

Balen AH

1993

Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

8298311

Steck T

1993

[Is determination of the free androgen index for hormone screening in polycystic ovaries of value?].

8298514

Oppermann K

1993

Serum LH levels in the differential diagnosis of hirsute anovulatory women.

8300842

Br?nnstr?m M

1993

Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function.

8311156

Efremova LD

1993

[A trial of using the preparation difenin in the polycystic ovary syndrome].

8312836

Herter LD

1993

Association of ovarian volume and serum LH levels in adolescent patients with menstrual disorders and/or hirsutism.

8314008

Krook A

1994

Molecular scanning of the insulin receptor gene in syndromes of insulin resistance.

8314200

Pasquali R

1993

Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.

8314207

Paradisi R

1993

Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.

8314962

Scheele F

1993

The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome.

8316557

Greenblatt EM

1993

Laparoscopic ovarian drilling in women with polycystic ovarian syndrome.

8320676

van Gelderen CJ

1993

Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases.

8320677

Fulghesu AM

1993

Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.

8323165

Franks S

1993

Prevalence of and etiological factors in polycystic ovarian syndrome.

8323166

Bringer J

1993

Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles.

8323167

Pugeat M

1993

Androgens in polycystic ovarian syndrome.

8323169

Minanni SL

1993

Pulsatile secretion of serum gonadotropins in hirsute women with and without polycystic ovarian syndrome.

8323170

Fauser BC

1993

Gonadotropins in polycystic ovarian syndrome.

8323171

Rosenfield RL

1993

Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.

8323172

Hall JE

1993

New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome.

8323173

New MI

1993

Nonclassical congenital adrenal hyperplasia and the polycystic ovarian syndrome.

8323174

Dewailly D

1993

Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian syndrome.

8323175

Fox R

1993

Ultrasound diagnosis of polycystic ovaries.

8323176

Maubon A

1993

Magnetic resonance imaging of normal and polycystic ovaries. Preliminary results.

8323177

Batrinos ML

1993

Diagnostic dilemmas in polycystic ovarian syndrome.

8323178

Crowley WF Jr

1993

An overview of the diagnostic considerations in polycystic ovarian syndrome.

8323179

Markussis V

1993

Therapeutic use of gonadotropin-releasing hormone agonists in polycystic ovarian syndrome.

8323181

Prelevi? GM

1993

Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.

8323182

Golland IM

1993

Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.

8323183

Tarlatzis BC

1993

Assisted reproduction techniques in polycystic ovarian syndrome.

8323186

Schoemaker J

1993

New approaches with the FSH threshold principle in polycystic ovarian syndrome.

8323187

Franks S

1993

Low-dose gonadotropin therapy in polycystic ovarian syndrome.

8323188

Palumbo A

1993

The ovarian renin-angiotensin system in polycystic ovarian syndrome.

8323191

Dunaif A

1993

Insulin resistance in polycystic ovarian syndrome.

8323193

Yen SS

1993

Interface between extra- and intraovarian factors in polycystic ovarian syndrome.

8329651

Giudice LC

1993

The potential roles of intraovarian peptides in normal and abnormal mechanisms of reproductive physiology.

8330448

Jacobs HS

1993

PCO in normal women and fertility of the population.

8330449

B?dis J

1993

PCO in normal women and fertility of the population.

8334480

Pearce JM

1993

Hypersecretion of luteinizing hormone: cause or marker of subfertility and miscarriage?

8334748

Grulet H

1993

Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.

8334753

Carey AH

1993

Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.

8336861

Resta L

1993

Morphologic precursors of ovarian epithelial tumors.

8336863

Fulghesu AM

1993

Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease.

8339821

Jaatinen TA

1993

Hormonal responses to physical exercise in patients with polycystic ovarian syndrome.

8339824

Palumbo A

1993

Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease.

8345068

van Weissenbruch MM

1993

Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.

8345070

Watson H

1993

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage.

8345073

Takahashi K

1993

Morphological assessment of polycystic ovary using transvaginal ultrasound.

8345091

Balen AH

1993

Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.

8347381

Rosenlund BL

1993

Effects of insulin on free amino acids in plasma and the role of the amino acid metabolism in the etiology of diabetic microangiopathy.

8348163

Bregieiro LO

1993

Ovulation induction with low doses of pure follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.

8348699

Pasquali R

1993

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women.

8358893

Fauser BC

1993

The step-down principle in gonadotrophin treatment and the role of GnRH analogues.

8358898

Greenblatt E

1993

Surgical options in polycystic ovary syndrome patients who do not respond to medical ovulation induction.

8362057

Occhipinti KA

1993

The ovary. Computed tomography and magnetic resonance imaging.

8365685

Baron JJ

1993

[Differential diagnosis of hirsutism in girls between 15-19 years old].

8370711

Yamoto M

1993

Immunohistochemical localization of inhibin subunits in polycystic ovary.

8372596

Schoot DC

1993

Growth of the dominant follicle is similar to normal in patients with gonadotrophin-stimulated polycystic ovary syndrome exhibiting monofollicular development during a decremental dose regimen.

8374662

Masland RP Jr

1993

Adolescent medicine.

8374664

Siegel SF

1993

Polycystic ovary syndrome.

8374678

Winter JS

1993

Hyperandrogenism in female adolescents.

8375585

Dunaif A

1993

Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.

8381802

Barnes RB

1993

Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.

8382432

Dale O

1993

Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome.

8387433

Wiczyk HP

1993

Fatal attraction.

8388405

Rittmaster RS

1993

The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.

8391404

Stewart PM

1993

The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome.

8396511

Sahin Y

1993

17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.

8401681

Yoshino K

1993

Peripheral catecholamine metabolites and menstrual irregularity in patients with polycystic ovaries.

8402388

Cooke GM

1993

Steroidogenic enzyme activities in rat polycystic ovaries.

8403620

Filicori M

1993

Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization.

8404454

Grulet H

1993

Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index.

8405514

Scheele F

1993

The relationship between follicle-stimulating hormone dose and level and its relevance for ovulation induction with adjuvant gonadotropin-releasing hormone-agonist treatment.

8405515

Buyalos RP

1993

The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome.

8405516

Elkind-Hirsch KE

1993

Insulin resistance improves in hyperandrogenic women treated with Lupron.

8405534

Hornnes P

1993

Recombinant human follicle-stimulating hormone treatment leads to normal follicular growth, estradiol secretion, and pregnancy in a World Health Organization group II anovulatory woman.

8405640

Meirow D

1993

Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities.

8406342

Ghosh S

1993

Subclinical hypothyroidism: a determinant of polycystic ovary syndrome.

8408513

Anttila L

1993

Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease.

8408537

Mascarenhas L

1993

Severe ovarian hyperstimulation syndrome, selective embryo reduction and heterotopic pregnancy.

8413434

Isoj?rvi JI

1993

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.

8413946

Herzog AG

1993

A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy.

8419197

Caruso A

1993

Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.

8419227

Katz E

1993

The potential relevance of growth hormone to female reproductive physiology and pathophysiology.

8419796

Herzog AG

1993

Hormonal influences on spasmodic torticollis: a case report.

8425623

Ditkoff EC

1993

Time-resolved fluoroimmunoassay compared with radioimmunoassay of luteinizing hormone.

8425642

Tjaden B

1993

Time-related effects of RU486 treatment in experimentally induced endometriosis in the rat.

8432769

Peiris AN

1993

Relationship of insulin secretory pulses to sex hormone-binding globulin in normal men.

8435902

Buckler HM

1993

Efficacy of low dose purified FSH in ovulation induction following pituitary desensitization in polycystic ovarian syndrome.

8435903

Conway GS

1993

Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin.

8447386

Rosenbaum D

1993

Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

8449445

Ryuko K

1993

Morular metaplasia of the endometrium in a patient with polycystic ovary syndrome.